Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. SCA Pharmaceuticals, LLC
FDA Inspection
•SCA Pharmaceuticals, LLC•October 20, 2023

SCA Pharmaceuticals, LLC – FDA Inspection, Oct 20, 2023

Record Details

This FDA Inspection record concerns SCA Pharmaceuticals, LLC, with an inspection on October 20, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
SCA Pharmaceuticals, LLC
Inspection Date
October 20, 2023
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • John P. Mistler (FDA Associated Person)
  • Jonah S. Ufferfilge (FDA Associated Person)
View Company Profile

ID · 8ed46b4e-f317-4436-8ba7-6ec1a985a96b

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1221018
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

20
  1. 21 CFR 211.68(b)Computer control of master formula records
  2. FD&C Act 503B(a)(10)(A)Drug product labels, fails to include
  3. 21 CFR 211.192Investigations of discrepancies, failures
  4. 21 CFR 211.103Actual vs. theoretical yields not determined
  5. 21 CFR 211.113(b)Procedures for sterile drug products
  6. 21 CFR 211.22(a)Lack of quality control unit
  7. 21 CFR 211.67(b)Written procedures not established/followed
  8. 21 CFR 211.63Equipment Design, Size and Location
  9. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
  10. 21 CFR 211.198(a)Complaint Handling Procedure

Showing 10 of 20 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of SCA Pharmaceuticals, LLC

3
DateClassificationOfficeProject area
March 13, 2026Not classifiedNew England District OfficeDrug Quality Assurance
December 20, 2024VAINew England District OfficeDrug Quality Assurance
March 5, 2018Not classifiedNew England District OfficeDrug Quality Assurance
Other documents for SCA Pharmaceuticals, LLC
  • FDA Inspection 1307176 - 2026-03-13
  • FDA Inspection 1252093 - 2024-12-20
  • FDA Inspection 1043107 - 2018-03-05

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore SCA Pharmaceuticals, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.